Načítá se...
Tailoring combinatorial cancer therapies to target the origins of adaptive resistance
The development of resistance to chemotherapy is a critical yet poorly understood phenomenon driving cancer-related deaths. We recently reported a study that explored the origins of adaptive chemotherapy resistance. During this investigation we unexpectedly discovered that inherent vulnerabilities w...
Uloženo v:
| Vydáno v: | Mol Cell Oncol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845182/ https://ncbi.nlm.nih.gov/pubmed/27308546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1030534 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|